Skip to Content

342 Results Found

  • Case Report
  • Open Access
7 Citations
1,097 Views
3 Pages

Schnitzler Syndrome, a Rare Autoinflammatory Disease. Complete Response to Il-1 Blockade

  • Paola Faggioli,
  • Antonio Tamburello,
  • Lucia Roncoroni and
  • Antonino Mazzone

12 December 2017

The Schnitzler syndrome (SCS) is a rare, late-onset acquired autoinflammatory syndrome often underdiagnosed. The diagnosis is based on the Lipsker and recently on validated Strasbourg diagnostic criteria (chronic urticarial rash, monoclonal gammopath...

  • Article
  • Open Access
23 Citations
6,762 Views
15 Pages

Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis

  • Ihsan Hammoura,
  • Renee H. Fiechter,
  • Shaughn H. Bryant,
  • Susan Westmoreland and ,
  • Gillian Kingsbury,
  • Wendy Waegell,
  • Sander W. Tas,
  • Dominique L. Baeten,
  • Marleen G. H. van de Sande and
  • Leonie M. van Duivenvoorde
  • + 6 authors+ 1 author

The tumor necrosis factor (TNF) and IL-23/IL-17 axes are the main therapeutic targets in spondyloarthritis. Despite the clinical efficacy of blocking either pathway, monotherapy does not induce remission in all patients and its effect on new bone for...

(This article belongs to the Special Issue Advances in the Pathogenesis and Treatment of Immune-Mediated Inflammatory Diseases)
  • Review
  • Open Access
7 Citations
3,778 Views
23 Pages

Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review

  • Hidenori Takahashi,
  • Toru Awaya,
  • Hiroki Nagamatsu,
  • Yugo Satake and ,
  • Ryutaro Hirose,
  • Naoya Toba,
  • Mio Toyama-Kousaka,
  • Shinichiro Ota,
  • Miwa Morikawa and
  • Masaharu Shinkai
  • + 8 authors+ 3 authors

26 September 2025

Background/Objectives: Eosinophilic myocarditis (EM) is a rare, life-threatening inflammatory cardiomyopathy driven by eosinophil cytotoxicity and extracellular trap formation. Interleukin-5 (IL-5) inhibition may disrupt this pathogenic cascade. We r...

(This article belongs to the Section Cardiovascular Medicine)
  • Brief Report
  • Open Access
5 Citations
3,529 Views
9 Pages

23 October 2024

Group B Streptococcus (GBS) is one of the most common bacteria responsible for placental and neonatal infection and inflammation resulting in lifelong neurobehavioral impairments. In particular, GBS-induced chorioamnionitis is known in preclinical mo...

(This article belongs to the Special Issue Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies)
  • Article
  • Open Access
29 Citations
4,725 Views
15 Pages

Blockade of the Adenosine A3 Receptor Attenuates Caspase 1 Activation in Renal Tubule Epithelial Cells and Decreases Interleukins IL-1β and IL-18 in Diabetic Rats

  • Wallys Garrido,
  • Claudia Jara,
  • Angelo Torres,
  • Raibel Suarez and ,
  • Claudio Cappelli,
  • Carlos Oyarzún,
  • Claudia Quezada and
  • Rody San Martín
  • + 3 authors+ 0 author

13 September 2019

Diabetic nephropathy (DN) is the main cause of end-stage renal disease, which remains incurable. The progression of DN is associated with progressive and irreversible renal fibrosis and also high levels of adenosine. Our aim was to evaluate the effec...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
6 Citations
4,697 Views
12 Pages

Enhancing Tumor Immunity with IL-12 and PD-1 Blockade: A Strategy for Inducing Robust Central Memory T Cell Responses in Resistant Cancer Model

  • Fentian Chen,
  • Kexin Wu,
  • Shiqi Lin,
  • Jinlong Cui and ,
  • Xiaoqing Chen,
  • Zhiren Zeng,
  • Na Yuan,
  • Mujin Fang,
  • Xue Liu and
  • Wenxin Luo
  • + 6 authors+ 1 author

20 November 2024

Background: Although immune checkpoint inhibitors (ICIs) have demonstrated efficacy in treating advanced cancers, their therapeutic success remains limited for many patients, with initial responders often experiencing resistance and relapse. Interleu...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
32 Citations
4,946 Views
14 Pages

1 October 2019

Aim: Triggering receptor expressed on myeloid cells-1 (TREM-1) is a modifier of local and systemic inflammation. There is clinical evidence implicating TREM-1 in the pathogenesis of periodontitis. However, a cause-and-effect relationship has yet to b...

(This article belongs to the Special Issue Periodontitis: From Dysbiotic Microbial Immune Response to Systemic Inflammation)
  • Article
  • Open Access
514 Views
14 Pages

Background: Immune checkpoint inhibitors and adoptive T-cell therapies have substantially improved cancer treatment outcomes, but their use is often limited by immune-related toxicities, including cytokine release syndrome. The role of interleukin (I...

(This article belongs to the Special Issue Advanced Research in Melanoma Metastasis)
  • Systematic Review
  • Open Access
45 Citations
7,552 Views
22 Pages

A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy

  • Marie-Eve Brien,
  • Virginie Gaudreault,
  • Katia Hughes,
  • Dexter J. L. Hayes and ,
  • Alexander E. P. Heazell and
  • Sylvie Girard
  • + 1 author+ 0 author

31 December 2021

Blockade of the interleukin-1 (IL-1) pathway has been used therapeutically in several inflammatory diseases including arthritis and cryopyrin-associated periodic syndrome (CAPS). These conditions frequently affect women of childbearing age and contin...

(This article belongs to the Special Issue Diagnostic or Therapeutic Strategies for Pregnancy Complications)
  • Article
  • Open Access
2 Citations
2,362 Views
29 Pages

IL-15 Complexes Combined with PD-1 Blockade Affect Immune Cell Distribution, Localization, and Immune Signatures in Regressing Versus Non-Regressing Metastatic Breast Tumors

  • Josef W. Goldufsky,
  • Anjelica F. Reyes,
  • Allie A. Heller,
  • Malia E. Leifheit and ,
  • Maram N. Albalawi,
  • Noah T. King,
  • Timothy M. Kuzel,
  • Jeffrey R. Schneider and
  • Amanda L. Marzo
  • + 4 authors+ 0 author

27 November 2025

Rapid advancements in understanding how the immune system can eliminate tumors have quickly translated into breakthroughs in developing cancer therapeutics. Immune checkpoint inhibitors (ICIs) have shown great promise in several cancers; however, res...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
17 Citations
3,917 Views
15 Pages

Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models

  • Junjie Ye,
  • Lingjuan Chen,
  • Julia Waltermire,
  • Jinshun Zhao and ,
  • Jinghua Ren,
  • Zongsheng Guo,
  • David L. Bartlett and
  • Zuqiang Liu
  • + 3 authors+ 0 author

29 February 2024

The success of cancer immunotherapy is largely associated with immunologically hot tumors. Approaches that promote the infiltration of immune cells into tumor beds are urgently needed to transform cold tumors into hot tumors. Oncolytic viruses can tr...

(This article belongs to the Special Issue Oncolytic Viruses: A Key Step toward Cancer Immunotherapy)
  • Review
  • Open Access
54 Citations
8,071 Views
17 Pages

Therapeutic Strategies for Targeting IL-1 in Cancer

  • Adrian Gottschlich,
  • Stefan Endres and
  • Sebastian Kobold

26 January 2021

Since its discovery, interleukin-1 has been extensively studied in a wide range of medical fields. Besides carrying out vital physiological functions, it has been implicated with a pivotal role in the progression and spreading of different cancer ent...

(This article belongs to the Special Issue Interleukin in Cancer Pathogenesis and Treatment)
  • Review
  • Open Access
1,810 Views
11 Pages

Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review

  • Joseph J. Neubecker,
  • Daniel W. Griepp,
  • Jeffrey P. Turnbull,
  • Joshua Caskey and ,
  • Shivum Desai,
  • Adam Mansour,
  • Rabia Ahmed,
  • Andrew Beggs,
  • Annie T. K. Griepp and
  • Prashant S. Kelkar
  • + 8 authors+ 3 authors

Craniopharyngiomas are rare, histologically benign but locally aggressive intracranial tumors that are associated with substantial visual, endocrine, and hypothalamic morbidity. Advances in molecular characterization have enabled the use of systemic...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Article
  • Open Access
29 Citations
7,640 Views
17 Pages

Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma

  • Olga A. Namakanova,
  • Ekaterina A. Gorshkova,
  • Ruslan V. Zvartsev,
  • Sergei A. Nedospasov and ,
  • Marina S. Drutskaya and
  • Ekaterina O. Gubernatorova
  • + 1 author+ 0 author

Combined anti-cytokine therapy is a promising therapeutic approach for uncontrolled steroid-resistant asthma. In this regard, simultaneous blockade of IL-4 and IL-13 signaling by Dupilumab (anti-IL-4Ra monoclonal antibody) was recently approved for s...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
20 Citations
3,727 Views
18 Pages

The main purpose of this study was to investigate whether the blockade of the interaction between the receptor activator of nuclear factor-κB (NF-ĸB) ligand (RANKL) and its receptor RANK as well as the blockade of NF-κB inhibitor kinase (IKK) and of...

(This article belongs to the Section Natural Products Chemistry)
  • Article
  • Open Access
1,053 Views
22 Pages

Rebuilding the Mucociliary Apparatus in ECRS: TSLP/IL-33 Signaling Synergy and the Residual Molecular Scar of DNASE1L3 Following IL-4/13 Blockade

  • Rikuto Fujita,
  • Takashi Ishino,
  • Takashi Oda,
  • Tomohiro Kawasumi and ,
  • Manabu Nishida,
  • Yuichiro Horibe,
  • Nobuyuki Chikuie,
  • Takayuki Taruya,
  • Takao Hamamoto and
  • Sachio Takeno
  • + 6 authors+ 1 author

15 May 2026

Background: Eosinophilic chronic rhinosinusitis (ECRS) is characterized by refractory nasal polyps and severely impaired mucociliary clearance (MCC). The molecular mechanisms underlying the modulation of mucociliogenesis following IL-4/13 blockade wi...

  • Brief Report
  • Open Access
17 Citations
3,096 Views
7 Pages

IL-6 Receptor Blockade Increases Circulating Adiponectin Levels in People with Obesity: An Explanatory Analysis

  • Stephan Wueest,
  • Eleonora Seelig,
  • Katharina Timper,
  • Mark P. Lyngbaek and ,
  • Kristian Karstoft,
  • Marc Y. Donath,
  • Helga Ellingsgaard and
  • Daniel Konrad
  • + 3 authors+ 0 author

29 January 2021

Human obesity is associated with decreased circulating adiponectin and elevated leptin levels. In vitro experiments and studies in high fat diet (HFD)-fed mice suggest that interleukin-6 (IL-6) may regulate adiponectin and leptin release from white a...

(This article belongs to the Special Issue Metabolic Health and Weight II)
  • Article
  • Open Access
7 Citations
3,931 Views
14 Pages

Peripheral Opioid Receptor Blockade Enhances Epithelial Damage in Piroxicam-Accelerated Colitis in IL-10-Deficient Mice

  • Xavier Mas-Orea,
  • Morgane Sebert,
  • Mehdi Benamar,
  • Camille Petitfils and ,
  • Catherine Blanpied,
  • Abdelhadi Saoudi,
  • Céline Deraison,
  • Frederick Barreau,
  • Nicolas Cenac and
  • Gilles Dietrich
  • + 5 authors+ 0 author

Mucosal CD4+ T lymphocytes display a potent opioid-mediated analgesic activity in interleukin (IL)-10 knockout mouse model of inflammatory bowel diseases (IBD). Considering that endogenous opioids may also exhibit anti-inflammatory activities in the...

(This article belongs to the Special Issue Regulation and Physiopathology of Gut Barrier)
  • Review
  • Open Access
6 Citations
7,216 Views
39 Pages

The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions

  • Andrea Pasta,
  • Luisa Bertin,
  • Amir Mari,
  • Francesco Calabrese and ,
  • Amir Farah,
  • Giulia Navazzotti,
  • Matteo Ghisa,
  • Vincenzo Savarino,
  • Edoardo Vincenzo Savarino and
  • Elisa Marabotto
  • + 6 authors+ 1 author

12 December 2025

Eosinophilic esophagitis (EoE) has emerged as a major cause of dysphagia and food impaction worldwide. This narrative review traces the evolving therapeutic pipeline for EoE, highlighting agents spanning from late-stage clinical development to final...

(This article belongs to the Special Issue New and Emerging Treatment Strategies for Gastrointestinal Diseases)
  • Review
  • Open Access
13 Citations
6,166 Views
23 Pages

IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance

  • Suprataptha U. Reddy,
  • Fatema Zohra Sadia,
  • Ales Vancura and
  • Ivana Vancurova

27 July 2024

IFNγ, a pleiotropic cytokine produced not only by activated lymphocytes but also in response to cancer immunotherapies, has both antitumor and tumor-promoting functions. In ovarian cancer (OC) cells, the tumor-promoting functions of IFNγ...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
2 Citations
3,220 Views
12 Pages

Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines

  • Shiting Xu,
  • Keita Miura,
  • Takehito Shukuya,
  • Sonoko Harada and ,
  • Masahiro Fujioka,
  • Wira Winardi,
  • Shoko Shimamura,
  • Kana Kurokawa,
  • Issei Sumiyoshi and
  • Kazuhisa Takahashi
  • + 12 authors+ 7 authors

11 February 2023

Cancer cachexia is associated with poor immunotherapeutic outcomes. This prospective observational study longitudinally evaluated the role of cachexia-related circulating cytokines in predicting the risk and benefit of PD-1/PD-L1 blockade in advanced...

(This article belongs to the Special Issue Cancer Cachexia: Molecular Insights and Clinical Implications)
  • Article
  • Open Access
20 Citations
4,791 Views
20 Pages

Selective Blockade of TNFR1 Improves Clinical Disease and Bronchoconstriction in Experimental RSV Infection

  • Dorothea R. Morris,
  • Maria Ansar,
  • Teodora Ivanciuc,
  • Yue Qu and ,
  • Antonella Casola and
  • Roberto P. Garofalo
  • + 1 author+ 0 author

17 October 2020

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis in infants and young children. Although some clinical studies have speculated that tumor necrosis factor (TNF)-α is a major contributor of RSV-mediated airway disease, expe...

(This article belongs to the Special Issue From RSV to hMPV: Role of Innate Immunity in Pathogenesis)
  • Communication
  • Open Access
12 Citations
6,103 Views
6 Pages

21 December 2022

The better understanding of the immunopathogenesis of psoriasis has led to the development of highly efficacious targeted therapies with favorable safety profiles. Among them, the class of Interleukin (IL)-17 antibodies are well established for the t...

(This article belongs to the Section Dermatology)
  • Commentary
  • Open Access
8 Citations
2,499 Views
6 Pages

21 February 2025

A growing number of systemic hereditary inflammatory diseases characterized by periodic fevers and elevated acute-phase proteins during flares has been linked to deregulated inflammasome function and excessive bioactivity of interleukin (IL)-1. All t...

(This article belongs to the Special Issue New Insights in Biomarkers of Autoimmune and Autoinflammatory Diseases)
  • Review
  • Open Access
553 Views
21 Pages

Periodontitis is a chronic, dysbiosis-driven inflammatory disease, that, unlike gingivitis, results in irreversible, tooth-supporting soft tissue and bone loss. Clarifying the molecular pathways that sustain the host inflammatory response is therefor...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
13 Citations
4,836 Views
14 Pages

12 April 2023

PD-1 blockade rescues failing anticancer immune responses, resulting in durable remissions in some cancer patients. Cytokines such as IFNγ and IL-2 contribute to the anti-tumor effect of PD-1 blockade. IL-9 was identified over the last decade a...

  • Article
  • Open Access
5 Citations
2,713 Views
11 Pages

Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy

  • Lijun Tan,
  • Katelyn Tondo-Steele,
  • Caroline Foster,
  • Carrie McIlwain and ,
  • Danielle E. Bolland,
  • Howard C. Crawford,
  • Andrew Sciallis and
  • Karen McLean
  • + 3 authors+ 0 author

26 September 2022

Antiestrogen therapy (AET) is an alternative to cytotoxic chemotherapy for recurrent ovarian cancer, yet the often short duration of response suggests mechanisms of resistance. We previously demonstrated that tumor microenvironment interleukin-6/leuk...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
50 Citations
9,247 Views
15 Pages

The interleukin 17 (IL-17) family, a subset of cytokines consisting of IL-17A-F, plays crucial roles in host defence against microbial organisms and the development of inflammatory diseases, including psoriasis (PsO), axial spondyloarthritis (axSpA),...

(This article belongs to the Special Issue Arthritis and Inflammatory Cytokine)
  • Article
  • Open Access
9 Citations
3,467 Views
22 Pages

Effects of the Interleukin-6 Receptor Blocker Sarilumab on Metabolic Activity and Differentiation Capacity of Primary Human Osteoblasts

  • Annett Klinder,
  • Janine Waletzko-Hellwig,
  • Marie-Luise Sellin,
  • Anika Seyfarth-Sehlke and ,
  • Markus Wolfien,
  • Franziska Prehn,
  • Rainer Bader and
  • Anika Jonitz-Heincke
  • + 3 authors+ 0 author

Interleukin (IL-) 6 is a key factor in the inflammatory processes of rheumatoid arthritis. Several biologic agents target the IL-6 signaling pathway, including sarilumab, a monoclonal antibody that blocks the IL-6 receptor and inhibits IL-6-mediated...

(This article belongs to the Section Biologics and Biosimilars)
  • Review
  • Open Access
15 Citations
12,068 Views
10 Pages

12 May 2010

A skewed ratio of pro-inflammatory to anti-inflammatory cytokines, elevated growth factor synthesis and T- and B-lymphocyte activation are 3 hallmarks of rheumatoid arthritis (RA) pathology. Interleukin-6 (IL-6), IL-7, IL-17, IL-12/IL-23 and growth f...

(This article belongs to the Special Issue Protein Kinase Inhibitors)
  • Article
  • Open Access
2 Citations
967 Views
16 Pages

Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases

  • Yinghua Zhu,
  • Fangfang Zhang,
  • Siping Li,
  • Zhihua Tian and ,
  • Zaixue Jiang,
  • Fen Lv,
  • Xiaomei Zeng,
  • Zhongjun Zhou,
  • Baimao Zhong and
  • Xiaomei Lu
  • + 6 authors+ 1 author

NLRP3-associated autoinflammatory diseases (NLRP3-AIDs) are rare autoinflammatory disorders caused by uncontrolled inflammasome activation. While IL-1β blockade is first-line therapy, many patients respond inadequately, highlighting a need for a...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
5 Citations
4,778 Views
18 Pages

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis

  • Janne W. Bolt,
  • Arno W. van Kuijk,
  • Marcel B. M. Teunissen,
  • Dennis van der Coelen and ,
  • Saïda Aarrass,
  • Daniëlle M. Gerlag,
  • Paul P. Tak,
  • Marleen G. van de Sande,
  • Maria C. Lebre and
  • Lisa G. M. van Baarsen
  • + 5 authors+ 0 author

Interleukin (IL)-17 and tumor necrosis factor-alpha (TNF)-α are key players in psoriatic arthritis (PsA) pathogenesis. While both cytokines can be therapeutically targeted with beneficial clinical outcome, it is unclear whether inhibiting one c...

(This article belongs to the Section Immunology and Immunotherapy)
  • Review
  • Open Access
86 Citations
10,989 Views
19 Pages

30 October 2018

Cytokines are key players in the initiation and propagation of inflammation in chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), bronchiectasis and allergic asthma. This makes them attractive targets for speci...

(This article belongs to the Special Issue The Interleukins in Health and Disease)
  • Article
  • Open Access
7 Citations
3,245 Views
17 Pages

Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma

  • Nicoletta Nastasi,
  • Amada Pasha,
  • Gennaro Bruno,
  • Angela Subbiani and ,
  • Laura Pietrovito,
  • Angela Leo,
  • Lucia Scala,
  • Lorena de Simone,
  • Gabriella Casazza and
  • Maura Calvani
  • + 10 authors+ 5 authors

27 September 2023

Osteosarcoma (OS) is the most common primary malignancy of the bone, highly aggressive and metastasizing, and it mainly affects children and adolescents. The current standard of care for OS is a combination of surgery and chemotherapy. However, these...

(This article belongs to the Section Cancer Metastasis)
  • Review
  • Open Access

Comparative Efficacy of Biologic Therapies for Psoriasis: Insights from Head-to-Head Studies

  • Adam Rafałowicz,
  • Julia Nowowiejska-Purpurowicz and
  • Iwona Flisiak

18 November 2026

Biologic therapies have substantially transformed the management of moderate-to-severe psoriasis, but differences in efficacy, speed of response, durability, and safety reflect the distinct immunological pathways targeted by individual agents. The ai...

(This article belongs to the Special Issue Skin Immune-Related Diseases: New Molecular Insights in Pathogenesis and Treatment)
  • Article
  • Open Access
9 Citations
3,006 Views
18 Pages

Resistance to checkpoint-blockade treatments is a challenge in the clinic. Both primary and acquired resistance have become major obstacles, greatly limiting the long-lasting effects and wide application of blockade therapy. Many patients with metast...

(This article belongs to the Special Issue Plasmid DNA for Gene Therapy and DNA Vaccine Applications)
  • Review
  • Open Access
7 Citations
4,766 Views
16 Pages

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C

  • Julia Peña-Asensio,
  • Henar Calvo,
  • Miguel Torralba,
  • Joaquín Miquel and ,
  • Eduardo Sanz-de-Villalobos and
  • Juan-Ramón Larrubia
  • + 1 author+ 0 author

3 March 2021

Hepatitis C virus (HCV)-specific CD8+ T cell response is essential in natural HCV infection control, but it becomes exhausted during persistent infection. Nowadays, chronic HCV infection can be resolved by direct acting anti-viral treatment, but ther...

(This article belongs to the Special Issue T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma)
  • Brief Report
  • Open Access
15 Citations
3,183 Views
10 Pages

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events

  • Stephanie L. Gu,
  • Tara Maier,
  • Andrea P. Moy,
  • Stephen Dusza and ,
  • David M. Faleck,
  • Neil J. Shah and
  • Mario E. Lacouture
  • + 2 authors+ 0 author

2 November 2023

Background: Immune-related cutaneous adverse events (ircAEs) are frequent and may reduce quality of life and consistent dosing. IL12/23 has been implicated in psoriasis, which is reminiscent of the psoriasiform/lichenoid ircAE phenotype. We report th...

(This article belongs to the Special Issue Immune-Related Adverse Effects of Checkpoint Inhibitors in Cancer Patients)
  • Review
  • Open Access
8 Citations
4,165 Views
13 Pages

14 September 2023

Global health efforts have increased against infectious diseases, but issues persist with pathogens like Group B Streptococcus (GBS). Preclinical studies have elaborated on the mechanistic process of GBS-induced chorioamnionitis and its impact on the...

(This article belongs to the Special Issue Insights in Pregnancy Immunobiology and the Maternal–Placental–Fetal Interaction in Health and Disease)
  • Article
  • Open Access
6 Citations
4,198 Views
16 Pages

Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade

  • Aline de Oliveira Rezende,
  • Rafaella Santos Sabóia,
  • Adeliane Castro da Costa,
  • Diana Messala Pinheiro da Silva Monteiro and ,
  • Adrielle Zagmignan,
  • Luis Ângelo Macedo Santiago,
  • Rafael Cardoso Carvalho,
  • Paulo Vitor Soeiro Pereira,
  • Ana Paula Junqueira-Kipnis and
  • Eduardo Martins de Sousa
  • + 5 authors+ 0 author

Tuberculous granuloma formation is mediated by hypoxia-inducible factor 1 alpha (HIF-1α), and is essential for establishing latent tuberculosis infection (LTBI) and its progression to active tuberculosis (TB). Here, we investigated whether HIF-...

(This article belongs to the Topic Infectious Diseases)
  • Communication
  • Open Access
22 Citations
3,510 Views
10 Pages

The Dual Role of the β2-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis

  • Mikhail Melnikov,
  • Vladimir Rogovskii,
  • Anastasiya Sviridova,
  • Anna Lopatina and ,
  • Mikhail Pashenkov and
  • Alexey Boyko
  • + 1 author+ 0 author

Norepinephrine is a neurotransmitter that also has an immunomodulatory effect and is involved in multiple sclerosis (MS) pathogenesis. This study aimed to clarify the role of the β2-adrenoreceptor in the norepinephrine-mediated modulation of int...

(This article belongs to the Special Issue Advances in Mechanisms, Diagnosis and Therapy of Multiple Sclerosis and Other Demyelinating Diseases)
  • Article
  • Open Access
102 Citations
6,941 Views
16 Pages

Interleukin (IL)-6 plays a crucial role in the progression, invasion, and metastasis of breast cancer. Triple-negative breast cancer (TNBC) cell line MDA-MB-231 is known for its aggressive metastasis. Epithelial to mesenchymal transition (EMT) is a c...

(This article belongs to the Special Issue Perspectives on the Health Benefits of Flavonoids)
  • Article
  • Open Access
21 Citations
4,728 Views
16 Pages

STAT1 Is Required for Decreasing Accumulation of Granulocytic Cells via IL-17 during Initial Steps of Colitis-Associated Cancer

  • Yael Delgado-Ramirez,
  • Itzel Baltazar-Perez,
  • Yamileth Martinez,
  • Blanca E. Callejas and ,
  • Itzel Medina-Andrade,
  • Jonadab E. Olguín,
  • Norma L. Delgado-Buenrostro,
  • Yolanda I. Chirino,
  • Luis I. Terrazas and
  • Sonia Leon-Cabrera
  • + 5 authors+ 0 author

Signal transducer and activator of transcription 1 (STAT1) acts as a tumor suppressor molecule in colitis-associated colorectal cancer (CAC), particularly during the very early stages, modulating immune responses and controlling mechanisms such as ap...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
9 Citations
3,106 Views
21 Pages

The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis

  • Christopher Sherry,
  • Neda Dadgar,
  • Zuqiang Liu,
  • Yong Fan and ,
  • Kunhong Xiao,
  • Ali H. Zaidi,
  • Vera S. Donnenberg,
  • Albert D. Donnenberg,
  • David L. Bartlett and
  • Patrick L. Wagner
  • + 5 authors+ 0 author

5 September 2025

Peritoneal carcinomatosis (PC) is a late-stage manifestation of abdominopelvic malignancies with poor prognosis and limited treatment options. Unique biochemical mechanisms within the peritoneal cavity play a key role in disease progression and resis...

(This article belongs to the Section Gastrointestinal Oncology)
  • Review
  • Open Access
31 Citations
5,514 Views
18 Pages

The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma

  • Nevena Ladjevac,
  • Marija Milovanovic,
  • Andra Jevtovic,
  • Dragana Arsenijevic and ,
  • Bojana Stojanovic,
  • Milica Dimitrijevic Stojanovic,
  • Bojan Stojanovic,
  • Nebojsa Arsenijevic,
  • Aleksandar Arsenijevic and
  • Jelena Milovanovic
  • + 5 authors+ 0 author

Elucidating the inflammatory mechanisms underlying formation and progression of oral squamous cell carcinoma (OSCC) is crucial for discovering new targeted therapeutics. The proinflammatory cytokine IL-17 has proven roles in tumor formation, growth,...

(This article belongs to the Special Issue Cancer Treatment: New Drugs and Strategies)
  • Review
  • Open Access
662 Views
13 Pages

20 September 2026

Ulcerative colitis (UC) remains difficult to control in a substantial proportion of patients despite an expanding range of advanced therapies. Interleukin-7 (IL-7) is a homeostatic cytokine that supports lymphocyte survival, persistence and intestina...

(This article belongs to the Special Issue Innovations in the Diagnosis and Treatment of Inflammatory Bowel Disease)
  • Article
  • Open Access
3 Citations
2,295 Views
16 Pages

8 August 2025

Persistent type I interferon (IFN-I) signaling compromises adaptive anti-HIV-1 T cell immunity and promotes viral reservoir persistence, yet its effects on innate lymphoid cells during chronic infection remain unclear. Through integrated single-cell...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
13 Citations
4,166 Views
20 Pages

Redundancy in Innate Immune Pathways That Promote CD8+ T-Cell Responses in AAV1 Muscle Gene Transfer

  • Ning Li,
  • Sandeep R. P. Kumar,
  • Di Cao,
  • Maite Munoz-Melero and ,
  • Sreevani Arisa,
  • Bridget A. Brian,
  • Calista M. Greenwood,
  • Kentaro Yamada,
  • Dongsheng Duan and
  • Roland W. Herzog
  • + 5 authors+ 0 author

24 September 2024

While adeno-associated viral (AAV) vectors are successfully used in a variety of in vivo gene therapy applications, they continue to be hampered by the immune system. Here, we sought to identify innate and cytokine signaling pathways that promote CD8...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
54 Citations
11,591 Views
19 Pages

Daclizumab (DAC) is a humanized, monoclonal antibody that blocks CD25, a critical element of the high-affinity interleukin-2 receptor (IL-2R). DAC HYP blockade of CD25 inhibits effector T cell activation, regulatory T cell expansion and survival, and...

(This article belongs to the Special Issue Multiple Sclerosis: Diagnosis and Treatment)
  • Article
  • Open Access
5 Citations
4,577 Views
20 Pages

An In Vivo Inflammatory Loop Potentiates KRAS Blockade

  • Kristina A. M. Arendt,
  • Giannoula Ntaliarda,
  • Vasileios Armenis,
  • Danai Kati and ,
  • Christin Henning,
  • Georgia A. Giotopoulou,
  • Mario A. A. Pepe,
  • Laura V. Klotz,
  • Anne-Sophie Lamort and
  • Georgios T. Stathopoulos
  • + 8 authors+ 3 authors

KRAS (KRAS proto-oncogene, GTPase) inhibitors perform less well than other targeted drugs in vitro and fail clinical trials. To investigate a possible reason for this, we treated human and murine tumor cells with KRAS inhibitors deltarasin (targeting...

(This article belongs to the Special Issue Resistance to Targeted Therapies in Human Cancer)

of 7